Recent Updates

Published: 
Mar 2, 2021
Chapter 15

Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. This chapter describes the preparation of irradiated, washed, and CMV seronegative cellular blood components (red blood cells and platelets) and the clinical setting in which they are of greatest benefit.

Transfusion
Modified on: 
Feb 12, 2021

http://cancovid19plasma.ca/This repository aims to support Canadian transfusion medicine health care professionals during the COVID-19 pandemic. It will be updated regularly as new information is available. In addition, the public and donors can learn more about how Canadian Blood Services is responding to COVID-19 by visiting blood.ca/covid-19.

Transfusion
Published: 
Jan 15, 2021
Chapter 2

Whole blood donations are separated into specific cellular (red blood cells and platelets) and plasma components. Transfusing the appropriate blood component to effectively provide for the clinical needs of patients optimizes use of donated blood.

This chapter describes the manufacturing process for the most commonly prepared blood components:

  • Red blood cells (RBC)
  • Platelets: pooled and apheresis
  • Frozen plasma (FP)
  • Apheresis fresh frozen plasma (AFFP)
  • Cryosupernatant plasma (CSP)
  • Cryoprecipitate
Transfusion

Upcoming Events

When
March 9, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

More details to follow.

 

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Transfusion
When
March 16, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

More details to follow.

 

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Transfusion
When
March 25, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

More details to follow.

 

Note: This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Transfusion

Blog

Modified on: 
Feb 22, 2021

For the 200 Nova Scotians waiting for a lifesaving organ or tissue transplant, new legislation offers hope.

Organs and Tissues

Modified on: 
Feb 17, 2021

A study conducted by researchers in the University of Toronto QUEST program, a research collaborative supported by Canadian Blood Services, looked at what can be done to reduce the number of inappropriate red blood cell transfusions in hospitals.

Transfusion

Modified on: 
Feb 8, 2021

With an anticipated global shortage of immune globulin products, finding alternatives to IVIg can help improve availability of a drug in high demand. A recent study shows that eltrombopag, an oral medication that stimulates the production of platelets, is an effective alternative to IVIg for patients with immune thrombocytopenia who need surgery.

Transfusion